Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

203.49
+2.761.37%
Post-market: 204.931.44+0.71%18:35 EDT
Volume:2.05M
Turnover:414.24M
Market Cap:315.61B
PE:31.11
High:204.34
Open:199.78
Low:199.23
Close:200.73
52wk High:212.71
52wk Low:122.48
Shares:1.55B
Float Shares:1.54B
Volume Ratio:0.88
T/O Rate:0.13%
Dividend:3.13
Dividend Rate:1.54%
EPS(TTM):6.54
EPS(LYR):6.54
ROE:22.84%
ROA:8.19%
PB:6.49
PE(LYR):31.11

Loading ...

TrumpRx Is Here. Most People Won't Benefit. -- Barrons.com

Dow Jones
·
Feb 07

Bilateral Collaboration Accelerates as UK Prime Minister's Visit Highlights New Logic for Sino-British Cooperation

Deep News
·
Feb 06

AstraZeneca's Novel Bispecific Antibody Receives Clinical Trial Approval in China

Stock News
·
Feb 06

AstraZeneca PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
Feb 06

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live
·
Feb 06

NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer

prnewswire
·
Feb 03

AstraZeneca Expects FDA Decision on Updated Subcutaneous Saphnelo Application in H1 2026

MT Newswires Live
·
Feb 03

AstraZeneca (AZN.US) Stock Drops Nearly 2% as FDA Rejects Self-Injectable Lupus Drug Application

Stock News
·
Feb 03

AstraZeneca Says Breast Cancer Treatment Granted US FDA Priority Review

MT Newswires Live
·
Feb 03

Earning Preview: AstraZeneca PLC Q4 revenue is expected to increase by 8.99%, and institutional views are bullish

Earnings Agent
·
Feb 03

AstraZeneca rises 106.9%

TIPRANKS
·
Feb 03

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Feb 03

AstraZeneca’s Imfinzi perioperative regimen recommended for approval in EU

TIPRANKS
·
Feb 02

AstraZeneca (AZN.US) Lists on NYSE, Intensifying US Focus and Potentially Weakening London's Status

Stock News
·
Feb 02

AstraZeneca to Begin NYSE Trading; Says Imfinzi Recommended by EU as Gastric Cancer Treatment

MT Newswires Live
·
Feb 02

CICC Maintains "Outperform" Rating on CSPC PHARMA (01093) Following Major AstraZeneca Collaboration

Stock News
·
Feb 02

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Korro Bio (KRRO) and AstraZeneca (AZN)

TIPRANKS
·
Feb 01

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Jan 30

AstraZeneca (AZN) Moves Deeper into Weight Loss Market with New $18.5B CSPC Agreement

TIPRANKS
·
Jan 30

AstraZeneca Pays Top Dollar for Early-Stage Obesity Drugs -- Market Talk

Dow Jones
·
Jan 30